patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · small molecule
Drug for Unspecified Dermatological Disorders
Phase 1updated 2mo agoby TBT Pharma Inc🔗 ChEMBL
Phase 1community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 16 approved and 67 investigational indications.
targets
Neutrophil collagenaseInterstitial collagenaseBacterial 70S ribosomeCollagenase 3Matrilysin
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that